Abbonarsi

A sequential, multiple-assignment, randomized trial of analgesic strategies for acute musculoskeletal Pain - 15/07/24

Doi : 10.1016/j.ajem.2024.05.005 
Benjamin W. Friedman, MD a, , Yen Ting Chen, MD b, Caron Campbell, MD a, Rebecca Nerenberg, MD a, Freda Afrifa, PharmD c, Kristen Schimmrich, MD a, Victoria Adewunmi, MD a, Jesse Baer, MD a, Eddie Irizarry, MD a
a Department of Emergency Medicine, Montefiore-Einstein, Albert Einstein College of Medicine, Bronx, NY, USA 
b Department of Emergency Medicine, Chi-Mei Medical Center, Tainan, Taiwan 
c Pharmacy Department, Montefiore-Einstein, Bronx, NY, USA 

Corresponding author at: Departments of Emergency Medicine (All except FA and YTC) and Pharmacy (FA), Montefiore-Einstein, Albert Einstein College of Medicine, Bronx, NY, USA.Departments of Emergency Medicine (All except FA and YTC) and Pharmacy (FA), Montefiore-EinsteinAlbert Einstein College of MedicineBronxNYUSA

Abstract

Background

Most methodologically rigorous, ED-based, comparative effectiveness analgesic studies completed in the last two decades failed to find a clinically important difference between the comparators. We believe that many of these comparative effectiveness studies were biased towards the null hypothesis because some ED patients with intense pain will respond to relatively mild interventions. We hypothesized that including a run-in period would alter the results of an acute pain RCT.

Methods

We conducted a sequential, multiple-assignment, randomized study. Adults with acute moderate/severe musculoskeletal pain were randomized (3:1 ratio) to run-in period or no run-in. We administered 650 mg acetaminophen to run-in participants. Those run-in patients who reported insufficient relief one-hour later were randomized (1:1 ratio) to ibuprofen 800mg PO or ketorolac 20mg PO as were all participants randomized to no run-in. The primary outcome was achieving a clinically important improvement, defined as improvement ≥1.3 on a 0–10 scale. We built a logistic regression model including run-in/no run-in, ketorolac/ibuprofen, age and sex.

Results

Of 307 participants who received acetaminophen, 100 (32.6%) reported inadequate relief and were randomized to an NSAID. Of the 100 patients randomized to no run-in, 84/100 (84%) achieved the primary outcome versus 246/287 (86%) run-in participants (95% CI for difference = 2%:−7,10%). Among run-in participants who received an NSAID, 82/99(83%) achieved the primary outcome versus 84/100(84%) no run-in participants (p = 0.82). Among all ibuprofen participants, 44/49(90%) randomized to run-in and 42/50(84%) randomized to no run-in achieved the primary outcome. Among all ketorolac participants, 38/50(76%) randomized to run-in and 42/50 (84%) randomized to no run-in achieved the primary outcome. We observed the following results in a multivariable analysis: OR for ketorolac versus ibuprofen:0.60 (95% CI: 0.28, 1.28); OR for run-in versus no run-in:0.91(95% CI: 0.43, 1.93).

Conclusions

Among patients with acute musculoskeletal pain, using an acetaminophen first strategy did not alter pain outcomes.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : RCT, Pain, Analgesia, Acetaminophen, Ibuprofen, Ketorolac, Methodology, Run-in


Mappa


 This publication was supported in part by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore grant support (UL1TR001073)


© 2024  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 82

P. 15-20 - agosto 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Clinical characteristics and outcome of children with acute cryptorchid testicular torsion: A single-center, retrospective case series study
  • Zlatan Zvizdic, Asmir Jonuzi, Una Glamoclija, Denisa Zvizdic, Semir Vranic
| Articolo seguente Articolo seguente
  • ECG manifestations of occlusion of septal perforator of left anterior descending artery
  • Abhinav B. Anand, Pramod T. Gitte, Girish R. Sabnis, Ajay U. Mahajan

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.